Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy

H Koike1, K Misu, M Sugiura

  • 1Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Neurology
|July 14, 2004
PubMed
Abstract

Insights

Pathologic differences in familial amyloid polyneuropathy (FAP TTR Met30) correlate with age of onset. Early-onset FAP TTR Met30 shows small-fiber loss, while late-onset FAP TTR Met30 exhibits distinct nerve and ganglion pathology.

Area of Science:

  • Neuropathology
  • Amyloidosis Research
  • Genetics of Neurological Disorders

Background:

  • Familial amyloid polyneuropathy (FAP TTR Met30) presents with distinct clinical features based on age of onset and geographic origin.
  • Late-onset FAP TTR Met30 cases, unrelated to Japanese endemic foci, differ clinically from early-onset cases in endemic areas.

Purpose of the Study:

  • To conduct a comparative pathological analysis of early- and late-onset FAP TTR Met30.
  • To elucidate the distinct neuropathological characteristics associated with different FAP TTR Met30 phenotypes.

Main Methods:

  • Comparative pathological examination of sural nerve biopsies and autopsy tissues from 11 early-onset and 11 late-onset FAP TTR Met30 patients.
  • Assessment of amyloid deposition, neuronal cell loss, and fiber characteristics in peripheral nerves and autonomic/sensory ganglia.

Main Results:

  • Early-onset FAP TTR Met30 showed predominantly small-fiber loss, while late-onset cases displayed variable fiber sizes and axonal sprouting.
  • Amyloid deposition was more extensive in early-onset cases, with differential distribution in sympathetic versus sensory ganglia.
  • Late-onset cases showed more transthyretin-positive, Congo red-negative material and distinct extraneural amyloid deposition patterns (e.g., heart, hypophysis).

Conclusions:

  • Pathological findings in FAP TTR Met30 align with observed clinical variations between early- and late-onset presentations.
  • Distinct neuropathological profiles contribute to the differing clinical manifestations of FAP TTR Met30 based on onset age.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...